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RESEARCH ARTICLE
Social disparities in diabetes care: a general population study in Denmark
Andreas Heltberga,b, John Sahl Andersena, Jakob Kragstrupa, Volkert Siersmaa, Håkon Sandholdta and
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ABSTRACT
Objective: We investigated the association between socioeconomic factors and the attainment
of treatment goals and pharmacotherapy in patients with type 2 diabetes in Denmark.
Design: A cross-sectional population study.
Setting: The municipality of Naestved, Denmark.
Subjects: We studied 907 patients with type 2 diabetes identified from a random sample of
21,205 Danish citizens.
Main outcome measures: The proportion of patients who were not achieving goals for diabetes
care based on their HbA1c, LDL-cholesterol, blood pressure, and lifestyle, and the proportion of
patients who were treated with antihypertensive and cholesterol- and glucose-lowering
medication.
Methods: We investigated the association of the socioeconomic factors such as age, gender,
education, occupation, income, and civil status and attainment of treatment goals and pharma-
cotherapy in logistic regression analyses. We investigated effect modification of cardiovascular
disease and kidney disease.
Results: Middle age (40–65 years), low education level (i.e. basic schooling), and low household
income (i.e. less than 21,400 e per year) were associated with nonattainment of goals for dia-
betes care. The association of socioeconomic factors with attainment of individual treatment
goals varied. Patients with low socioeconomic status were more often obese, physically inactive,
smoking, and had elevated blood pressure. Socioeconomic factors were not associated with
treatment goals for hyperglycemia. Socioeconomic factors were inconsistently associated with
pharmacotherapy. There was no difference in contacts to general practitioners according to SES.
Conclusions: In a country with free access to health care, the socioeconomic factors such as
middle age, low education, and low income were associated with nonattainment of goals for
diabetes care.
KEY POINTS
 Middle age, low education, and low income were associated with nonattainment of goals for
diabetes care, especially for lifestyle goals.
 Patients with low socioeconomic status were more often obese, physically inactive, smoking,
and had elevated blood pressure.
 Association of socioeconomic factors with pharmacotherapy was inconsistent.
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Introduction
Epidemiological studies have repeatedly confirmed
association between incidence of type 2 diabetes mel-
litus (T2DM) and low socioeconomic status (SES) [1].
Mortality rates have fallen substantially, primarily due
to effective pharmacotherapy and multifactorial dia-
betes interventions [2]. However, trends have been
reported less favorable among patients with low SES
even in countries with equal access to health care
[3,4]. Associations between low SES and mortality in
patients with T2DM have not been fully explained
[5,6]. Reduced survival could be imputed to differences
in the attainment of treatment goals and a lower level
of pharmacotherapy among patients with low SES [6].
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Patients with low SES may have difficulty bearing the
costs of the multidrug regimens in T2DM [7], and medi-
cation adherence in general has been reported to be
influenced by SES [7–9]. Adherence to recommended
lifestyle changes could be a challenge for people with
low SES [10]. Studies suggest that differences in clinical
profiles between different SES groups are not the result
of treatment, but rather that lifestyle factors are major
contributors to these findings in Western countries [11].
It has been argued that drug coverage and differences
in cardiovascular disease (CVD) burden are influenced
by universal access to prescription drugs [3]. Despite
the near universal health-care coverage in most
European countries (including Denmark), income-
related inequality in the use of physician services has
been observed [12]. In a recent Danish study, the num-
ber of consultations for patients with diabetes with
their general practitioner (GP) increased with decreas-
ing SES [13]. Moreover social differences in the quality
of diabetes care can be modified [10].
The aim of this study was to investigate how social
disparity affects the attainment of treatment goals and
pharmacotherapy in patients with T2DM in a country
(Denmark) with universal health care.
Materials and methods
Setting
This study was part of the cross-sectional study named
the Danish General Suburban Population Study
(GESUS). GESUS was conducted in the Danish Naestved
Municipality, with approximately 80,000 inhabitants
and a mix of urban and rural settings. GESUS was
implemented to facilitate epidemiological research, and
analyzes the occurrence of comorbidities (e.g. T2DM),
mortality, and to derive new knowledge of risk factors.
The study design has been reported elsewhere [14].
The Danish health-care system is mainly tax-financed
and based on the egalitarian principle of equal health-
care access for equal health-care needs. In Denmark,
patients with high expenditure on prescription drugs
(e.g. patients suffering from T2DM) are for the most
part compensated through the system. Diagnosis and
routine care for T2DM are usually provided by GPs, who
function as gatekeepers for specialist care and are
responsible for more than 90% of all prescriptions [15].
Study population
GESUS recruited subjects from January 2010 through
October 2013. The criteria for inclusion were Danish
citizenship and residency in the Naestved Municipality.
The GESUS researchers contacted all people over 30
years of age and a computer-generated 25% random
selection of the population aged 20–30 years by mail
and invited them to participate by attending a health
examination. If individuals had not responded within 3
weeks of their scheduled attendance period, a
reminder was sent with a new scheduled period. The
total study population was 21,205 (43.2% of the
49,115 people invited to participate), and 20,876 indi-
viduals completed a health examination and a ques-
tionnaire. Participants were predominantly of Danish
or other Scandinavian descent (98.9%) [14].
Questionnaire
A paper-form questionnaire, similar to those used for
the Copenhagen City Heart Study (CCHS) and the
Copenhagen General Population Study (CGPS) [16],
was issued at the beginning of the examination and
was a prerequisite for attending the health examin-
ation. The questionnaire was tested in a pilot-study
involving 60 volunteers and it was reviewed and
revised for understandability and relevance.
Patients with T2DM were identified as those partici-
pants who answered yes to one of the following ques-
tions: “Do you have diabetes?” or “Are you being
treated with glucose-lowering medication?”. We
excluded patients with Type 1 diabetes mellitus, which
was defined as patients with insulin-treated diabetes
diagnosed before the age of 30. Patients recorded age
of onset of DM and whether they had been in contact
with their GP or hospitalized in the prior 12 months.
Patients with CVD were identified as people who
reported a diagnosis of myocardial infarction, stroke,
ischemic heart disease, or who suffered from angina
pectoris. Information regarding treatment with antihy-
pertensive, cholesterol, and glucose-lowering drugs
was recorded in the questionnaire. Participants
answered questions about lifestyle including current
smoking status and level of physical activity. Physical
activity was classified in accordance with international
and national guidelines for patients suffering from
T2DM [17,18]. Patients were labeled physically inactive
if they answered: “Passive or less than 2 h of light
activity per week” or “Light physical activity (i.e. walk-
ing, garden work) for 2–4 h per week”. Patients were
classed as physically active if they answered: “More
than 4 h of light physical activity” or “Strenuous work-
out (sweating and breathing hard) for 2–4 h per week”.
Information on socioeconomic factors was also col-
lected in the questionnaire including highest attained
educational level: Only basic schooling (<12 years of
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primary, secondary, and high-school); vocational train-
ing (1–3 years); short academic (1–3 years); long aca-
demic (>3 years e.g. university degree), civil status,
total annual household-income, and occupation; work-
ing: Employed, self-employed or assisting spouse; wel-
fare benefits: Unemployed, long-term sick leave, early
retirement for health reasons, homemaker; and retired:
senior citizen (the Danish retirement age was 67 years).
Health examination
All GESUS participants had their blood pressure (BP)
measured after 5-min rest, two consecutive measure-
ments performed on the left upper arm (apparatus
type A&D UA-787, A&D Medical, Tokyo, Japan), and
the second was registered. Weight and height were
measured and BMI was calculated. Fresh blood sam-
ples were drawn in a nonfasting state and analyzed
for HbA1c, estimated glomerular filtration rate (eGFR)
[19] and low-density lipoprotein cholesterol (LDL) cal-
culated from the Friedewald equation [20].
Outcome
We defined nonattainment of goals for T2DM based
on the following six criteria: hyperglycemia
(HbA1c>58mmol/mol, or >7.5%), hyperlipidemia (LDL
>2.5mmol/L), elevated BP (systolic-BP >140mm Hg),
obesity (BMI >30kg/m2) [21], current smoking, and
physical inactivity as defined by responses in the cor-
responding questionnaire.
GESUS was approved by the appropriate
Institutional Review Boards and Ethical Committees
(SJ-113, SJ-114) and reported to the Danish Data
Protection Agency. Written informed consent was
obtained from all participants. The investigation con-
forms to the principles of the Declaration of Helsinki.
Statistics
We used the statistical program SAS 9.4 (SAS Institute,
Cary, NC). Distribution of variables is shown as fre-
quencies with percentages (categorical variables), or
means with SD, (continuous variables).
We assessed the association between the socioeco-
nomic variables and the various aspects of diabetes
care and the use of pharmacotherapy as an odds ratio
(OR) from logistic regression models. In these models,
the socioeconomic factors were used, each in separate
analyses, as independent variables, and each goal for
diabetes care or the use of pharmacotherapy as binary
dependent variable. These analyses were adjusted for
gender and age (in three age groups as shown
in Table 1). In analyses with household income, civil
status was also adjusted for.
In order to investigate which of the socioeconomic
factors were most detrimental for diabetes care, we
calculated a measure for relative importance as the
average increase in McFadden’s R2 [22], (i.e. the pro-
portional reduction in error variance which corre-
sponds to the addition of a factor to a logistic
regression model across all multivariable logistic
regression models that can be constructed from the
remaining factors). This procedure partitions the R2 in
a model with all factors into the contributions of the
individual factors, and the relative importance is there-
fore reported as a percentage.
As a sensitivity analysis, we investigated the associ-
ation between socioeconomic factors and missing val-
ues for specific treatment goals and diabetes duration.
We investigated whether additional adjustment for
CVD, the presence of kidney disease (eGFR <49 L/min/
1.73 m2), and medication could explain an association
between SES and nonattainment of goals. We also
investigated effect modification by CVD or kidney dis-
ease on the association between SES and nonattain-
ment of goals.
Finally, we investigated how contact to GP and hos-
pitalization was associated with SES.
Results
Table 1 depicts baseline characteristics of the 907
patients with known T2DM. A small proportion of the
patients met all (2.8%), or all but one (14%), of their
treatment goals for T2DM care, while 415 (45.8%) did
not meet three or more of the six treatment goals for
diabetes care. Overall 50% of the patients were obese,
24.6% had HbA1c above 58mmol/mol, 38.6% had LDL
levels above 2.5mmol/l, and 60.3% had elevated sys-
tolic BP.
There were few missing values (5.5%) among the
clinical measurements (BMI, BP) and biochemical values
(HbA1c, LDL), and these were not associated with socioe-
conomic factors (Supplementary Table S1). In compari-
son, the self-reported data had more missing values and
we found missing values for physical exercise to be
associated with education (p¼ 0.029) and income
(p¼ 0.047) and missing information regarding choles-
terol-lowering therapy to be associated with living sin-
gle (Supplementary Table S2), but otherwise we could
not demonstrate missing values to be associated with
SES. Missing values for diabetes duration was overall
high (29%), but not associated with SES, and the
reported diabetes duration was significantly associated
with age and occupation (Supplementary Table S3).
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Attainment of treatment goals
Gender
Compared to men, women less physically active,
had lower odds of attaining LDL goals, and higher
odds of attaining glycemic (HbA1c) goals (Table 2)
even though they were less likely to receive
antidiabetic medication (Table 3), but overall men and
women did not differ on goals for diabetes care.
Age
Compared to individuals >65 years, younger individu-
als had higher odds for smoking and LDL >2.5mmol/l
Table 1. Characteristics, medication, and goals for diabetes care for 907 patients with
T2DM.
N (%) or {SD} Missing
Men, N (%) 510 (56.2) –
Age, mean {SD} 64.7 {10.9} –
25–40 years, N (%) 28 (3.1) –
>40–65 years, N (%) 398 (43.9)
>65 years, N (%) 481 (53.0)
Treatment, N (%)
Lifestyle only 165 (18.6) –
Glucose-lowering medication not insulin 543 (61.1) 18
Insulin 181 (20.4) 52
Cholesterol-lowering medication, N (%) 579 (65.4) 22
Antihypertensive medication, N (%) 605 (68.3) 21
Cardiovascular disease, N (%) 177 (20.5) 43
Kidney disease (eGFR <49 L/min/1.73 m2) 95 (10.5) 35
Diabetes duration years {SD} 9.0 {8.2} 259
Socioeconomic status
Education, N (%) 14
Basic-schooling (<12 years)a 247 (27.7)
Vocational training (1–3years) 358 (40.1)
Short academic (<3 years) 86 (11.6)
Long academic (>3 years, e.g. university) 202 (22.6)
Occupation, N (%) 21
Employed 280 (31.6)
Welfare benefits 127 (14.3)
Retired 479 (54.1)
Household income, N (%)c 127
<21,400 e 97 (12.4)
21,400–42,700 e 240 (30.8)
42,700–85,570 e 307 (39.4)
>85,570 e 136 (17.4)
Civil status, N (%) –
Married/cohabiting 658 (72.6)
Living single 249 (27.5)
Goals for diabetes care
Smoking, N (%) 156 (17.5) 14
Hyperglycemia
HbA1c, mean {SD} mmol/mol 51.8 {12.4} 11
HbA1c not in goal (>58mmol/mol), N (%) 223 (24.6) 11
Hypertension
Systolic BP, mean {SD} mmhg 145.5 {20.8} 3
Systolic BP not in goal (>140mm hg), N (%) 547 (60.3) 3
Hyperlipidemia
LDL, mean {SD} mmol/L 2.3{0.84} 57
LDL not in goal (>2.5mmol/L), N (%) 328 (38.6) 57b
Obesity
BMI, mean {SD} kg/m2 30.3{5.3} 10
Obese (BMI >30 kg/m2), N (%) 421 (46.9) 10
Physically inactive, N (%) 599 (69.9) 50
Number of treatment goals met (of 6), N (%) 117
6 (All treatment goals met) 22 (2.8)
5 111 (14.0)
4 242 (30.6)
3 260 (32.9)
2 127 (16.1)
1 25 (3.2)
0 (No treatment goals met) 3 (0.4)
aBasic schooling includes primary, secondary, and high-school.
bBlood sample missing, poor quality or too high triglyceride level (>4.4mmol/L) to calculate LDL value using
the Friedewald equation.
c1 e ¼ 7 dkr.
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and lower odds for having elevated BP. Individuals in
the age group 25–40 years were more physically active
and had overall better regulated T2DM even though
they were less likely to receive pharmacotherapy,
whereas the age group 40–65 years were more obese
and were less well regulated with attainment of the
HbA1c-goal compared to patients above 65 years.
Education
Compared to individuals with long academic educa-
tion, individuals with only basic schooling were less
well regulated; however, odds ratios for individual
goals or pharmacotherapy did not differ.
Income
Compared to individuals with the highest income,
lower income groups were less well regulated, had
higher odds ratios for smoking, had higher odds ratio
for elevated blood pressure, were less likely to be
physically active, and more likely to be obese.
Inconsistent results were found for the association of
income with pharmacotherapy.
Occupation
Compared to employed individuals, those unemployed
did not differ on the diabetes goals or regulation,
but were more likely to receive antihypertensive
medication.
Civil status
Compared to married/cohabiting individuals, individu-
als living single were more often smokers, had higher
odds ratios for LDL >2.5mmol/l, and were less likely
to receive cholesterol-lowering medication.
Overall, the relative importance of the socioeco-
nomic factors such as civil status, education, income,
and occupation for attainment of the different treat-
ment goals was between 20% and 29% but varied
according to specific treatment goal (Figure 1).
Additional adjustment for CVD and kidney disease
Supplementary Table S4 or adjustment for medication
(Supplementary Table S5) could not explain the associ-
ation between SES and not attaining goals for diabetes
care. Moreover could we not show any evidence of
effect modification.
Table 3. Socioeconomic factors and odds ratio (or) for no pharmacotherapy.
OR (CI 95%)
Not in glucose-lowering
medication, N¼ 889
Not in insulin therapy,
N¼ 855
Not in antihypertensive
medication, N¼ 886
Not in cholesterol-lowering
medication, N¼ 885
Gender
Male 1 1 1 1
Female 1.64 (1.13–2.35)c 1.05 (0.74–1.48) 1.15 (0.84–1.57) 0.94 (0.69–1.27)
Age
25–40 years 8.20 (3.57–18.87)c 3.04 (0.70–13.17) 22.50 (6.54–77.36)c 18.43 (5.39–63.00)c
>40–65 years 1.35 (0.93–1.96) 0.84 (0.59–1.18) 2.07 (1.51–2.84)c 1.57 (1.15–2.13)c
>65 years 1 1 1 1
Education
Basic schooling (<12 years) 0.71 (0.43–1.18) 1.16 (0.72–1.87) 0.82 (0.53–1.27) 0.84 (0.55–1.29)
Vocational training (1–3 years) 0.76 (0.48–1.19) 1.33 (0.86–2.07) 0.81 (0.54–1.22) 0.79 (0.54–1.17)
Short academic(<3 years) 0.60 (0.30–1.21) 1.06 (0.57–1.99) 0.67 (0.37–1.23) 0.95 (0.54–1.66)
Long academic (>3 years) 1 1 1 1
Household incomea
<21,400 e 0.79 (0.33–1.94) 0.74 (0.34–1.64) 0.76 (0.36–1.60) 0.75 (0.37–1.53)
21,400–42,700 e 0.99 (0.51–1.94) 0.74 (0.40–1.36) 0.75 (0.43–1.32) 0.83 (0.48–1.45)
42,700–85,570 e 1.06 (0.61–1.84) 0.95 (0.56–1.61) 0.58 (0.36–0.92)c 0.74 (0.47–1.17)
>85,570 e 1 1 1 1
Occupationb
Working 1 1 1 1
Welfare benefits 0.54 (0.29–1.01) 0.61 (0.36–1.06) 0.53 (0.32–0.87)c 0.76 (0.47–1.23)
Civil status
Married/cohabiting 1 1 1 1
Living single 0.94 (0.63–1.41) 1.31 (0.89–2.02) 0.99 (0.69–1.41) 1.62 (1.15–2.29)c
Cardiovascular disease
Yes 1 1 1 1
No 1.20 (0.74–1.96) 1.33 (0.81–2.00) 3.93 (2.34–6.58)c 3.68 (2.30–5.88)c
Kidney disease
Yes 1 1 1 1
No 1.28 (0.66–2.47) 1.34 (0.78–2.29) 1.59 (0.88–2.90) 1.11 (0.65–1.88)
OR analysis adjusted for gender, age (3 age groups), CVD and kidney disease (eGFR < 49 L/min/1.73 m2) (1 e ¼ 7 dkr).
aAnalysis on income, adjusted in addition for civil status.
bIn the analysis “working vs. welfare benefits”, excluding retired people (n¼ 423).
cp< 0.05.
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We could not show any significant difference
according to socioeconomic group on whether the
patients had been in contact with their GP the last
year (Table 4). However, hospitalizations were
increased among patients who were female, aged
25–40 years old, with low income, and with cardiovas-
cular or kidney disease.
Discussion
Statement of principal findings
Our data show that among patients with T2DM, ascer-
tained in a general population study in Denmark,
approximately 50% are obese and hypertensive, but
have on average good glycemic control. We showed
that middle age (40–65 years), low education level (i.e.
basic schooling), and low income were associated with
nonattainment of goals for diabetes care. The associ-
ation of socioeconomic factors with attainment of indi-
vidual treatment goals varied. Patients with low SES
were more often obese, physically inactive, smoking,
and had elevated blood pressure patients.
Socioeconomic factors were not associated with treat-
ment goals for hyperglycemia. We could not show any
consistent findings for the association between socioe-
conomic factors and pharmacotherapy. There were no
effect modifications of CVD and kidney disease on the
association of SES and nonattainment of goals. There
was no difference in contacts to GPs according to SES.
Strengths and limitations
This study is a large, cross-sectional study, with a
mixed invitation pattern (by gender, age, and resi-
dence) throughout the study period. The overall par-
ticipation rate in GESUS (43%) resembles that of other
general population studies in Europe that vary from
10% to 72% [23]. We have previously assessed selec-
tion bias among participants vs. nonparticipants [14]
and found that nonparticipants had a higher
Hyperglycemia
Hyperlipidemia
Hypertension
Obese
Physically inactive
Smoking
20100
Relative importance (%)
Civil status Education Income Occupation
Figure 1. Relative importance of socioeconomic factors in nonattainment of goals for diabetes care (e.g. the most important socio-
economic factor for smoking is income).
Notes: A measure for relative importance was calculated as the average increase in McFadden’s R2 (see “Statistics” section),
adjusted for gender and age. Smoking: Current smoker. Physically inactive (see text). Obese (BMI >30kg/m2). Hypertension (systolic
BP >140mmHg). Hyperlipidemia (LDL >2.5mmol/l). Hyperglycemia (HbA1c >58mmol/mol (>7.5%)).
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prevalence of diabetes and CVD, higher percentage of
men and individuals not living in a relationship being
on average 4 years younger than participants. A
recent, British investigation [24] has argued that there
is a socioeconomic gradient on attendance, with
socially deprived groups being less likely to attend.
Thus, nonparticipants may be more diseased and have
a worse SES status than participants, which could lead
to conservative estimates in our study.
The paper used self-reported data both on socioe-
conomic factors, disease history, lifestyle, and medica-
tion, which in general might be difficult to report. This
may cause risk of information bias and risk of both
under- and overreporting. SES data, medication, and
disease history might be difficult to report correct
which may be a source of recall bias, selective bias,
and social desirability [24]. We showed that for phys-
ical activity there is an increased number of missing
values among patients with low education and low
income. Also, in a cross-sectional study, we cannot tell
if treatment was sufficient and if the patients adhere
to all aspect of pharmacotherapy (time of day, dose,
or take the medication every day). In comparison to
the self-reported data, there were few missing values
(5.5%) among the clinical measurements (BMI, blood
pressure) and biochemical values (HbA1c, LDL). We did
not have access to the Danish registries on diagnoses
or medication, but this information could have
improved especially details on pharmacotherapy (gen-
eric and brand names).
We used relatively conservative treatment goals for
diabetes care, although these are fairly consistent with
other studies [25]. Even so, we could demonstrate a
relatively large proportion of patients not attaining
goals. These findings must be viewed in light of the
fact that participants included had no upper age limit
and no limitations on comorbid disease, resembling
patients in the general public treated in GP.
The association between achievement of treatment
goals and higher income could be explained by a
group of patients with a relatively low “disease bur-
den” having the capacity to work and to earn more
Table 4. Socioeconomic factors, CVD, and kidney disease and association with hospitalization and contact with the GP in the last
12 months.
Hospitalization in
last 12 months
N (174), 30 missing
N (%)
Hospitalization in
last 12 months
OR (CI 95%)
Contact with GP in
last 12 months
N (836), 19 missing
N (%)
Contact with GP in
last 12 months
OR (CI 95%)
Gender
Male 83 (16.3) 1 473 (92.8) 1
Female 91 (22.9) 1.61 (1.12–2.30) 363 (91.4) 1.25 (0.68–2.29)
Age
25–40 years 9 (32.1) 2.62 (1.10–6.22) 23 (82.1) 0.38 (0.10–1.42)
>40–65 years 76 (19.1) 1.30 (0.90–1.88) 361 (90.7) 0.65 (0.35–1.20)
>65 years 89 (18.5) 1 452 (94.0) 1
Education
Basic schooling (<12 years) 51 (20.7) 1.12 (0.68–1.83) 224 (90.7) 1.23 (0.55–2.77)
Vocational training (1–3 years) 64 (17.9 0.90 (0.57–1.43) 332 (92.7) 1.41 (0.68–2.92)
Short academic(<3 years) 15 (17.4) 0.97 (0.49–1.91) 81 (94.2) 1.23 (0.42–3.57)
Long academic (>3 years) 40 (19.8) 1 187 (92.6) 1
Household incomea
<21,400 e 20 (20.6) 3.15 (1.26–7.85) 86 (88.7) 1.15 (0.30–4.33)
21,400–42,700 e 53 (22.1) 3.79 (1.78–8.07) 219 (91.3) 0.99 (0.36–2.73)
42,700–85,570 e 61 (19.9) 3.01 (1.54–5.88) 292 (95.1) 1.76 (0.73–4.29)
>85,570 e 13 (9.6) 1 124 (91.2) 1
Occupationb
Working 43 (15.4) 1 253 (90.4) 1
Welfare benefits 32 (25.2) 1.57 (0.89–2.77) 119 (93.7) 1.95 (0.71–5.38)
Retired 97 (20.3) – 448 (93.5) –
Civil status
Married/cohabiting 123 (18.7) 1 613 (93.2) 1
Living single 51 (20.5) 1.05 (0.71–1.57) 223 (89.6) 0.55 (0.30–1.02)
Cardiovascular disease
Yes 50 (28.3) 2.15 (1.42–3.25) 172 (97.2) 2.79 (0.97–8.01)
No 116 (16.9) 1 628 (91.4) 1
Kidney disease
Yes 34 (35.8) 2.80 (1.71–4.59) 89 (93.7) 0.98 (0.34–2.86)
No 140 (17.2) 1 747 (92.0) 1
Odds ratio (OR) from logistic regression models adjusted for gender, age (3 age groups), CVD and kidney disease.p< 0.05.
aIncome analysis also adjusted for civil status.
bIn the analysis “working vs. welfare benefits”, excluding retired people (n¼ 423).
CVD: cardiovascular disease; GP: general practitioner.
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(“the healthy worker effect”). Cross-sectional studies,
like this, only have a single time point estimate, and
thus can only describe prevalence and not infer risk or
causality or prediction.
Findings in relation to other studies
A comparison of the participants of GESUS, a mixed
rural and urban population, with a more uniformly
urban population (CGPS) showed that GESUS partici-
pants are less physically active, have fewer current
smokers, higher anthropometric measures (BMI), and a
higher prevalence of undiagnosed diabetes and hyper-
tension [14]. This indicates that patients with T2DM in
more rural areas could have a different risk profile
compared to diabetes patients in more urban
environments.
A study by Dalsgaard et al. found that consultation
rates with the GP were higher for newly diagnosed
T2DM-patients with the lowest SES [13]. In our study,
we could not demonstrate any association between
SES group and contact to the general practitioner. This
result is in accordance with our finding that socioeco-
nomic factors were inconsistently associated with
pharmacotherapy could be interpreted as equality in
the delivery of health care for patients with diabetes
[6]. In this study, however, we did not have any infor-
mation on why patients consulted the general practi-
tioner, thus, there could be unexplained, hidden
reasons for consulting GP varying according to SES
groups.
We found that patients living single were more
often smokers, had higher odds ratios for LDL
>2.5mmol/l, and were less likely to receive choles-
terol-lowering medication. This finding is in accord-
ance with previous studies, suggesting that living with
a partner may provide support to the adaptation to
lifestyle changes and adherence to medical
treatment [9].
In particular, lifestyle factors differed between SES
groups, which is in line with other studies [8,11]. We
found that SES was not associated with attainment of
goals for HbA1c and that 24% did not meet treat-
ment goals for hyperglycemia; this is better than the
results from a recent large European study finding
that among people treated for T2DM 58.5% achieved
the glycated hemoglobin (HbA1c) target of<7.0%
[21]. Patients with low SES seem to have a similar
ratio of drug treatment in concordance with other
studies [11,26], although different observations have
been made [13] – especially in other health-care
systems.
Explanation of the findings and implications for
future research on clinical practice
Our data show, that even in a country with a universal
health-care system, socioeconomic factors such as edu-
cation level and low income were associated with non-
attainment of goals for diabetes care. The lack of
attainment of treatment goals for diabetes care among
patients with low SES may be interpreted as related to
lifestyle factors and not delivery of health care as
pharmacotherapy (a proxy for delivery of health care)
overall and contact to GP were not associated with
SES. However, other factors related to diabetes care –
organization and treatment schemes [6,27] and adap-
tion, which we did not assess, could also contribute to
the results [10,26,28]. Our study emphasizes the need
for future, prospective intervention studies [29] tar-
geted on SES in patients with T2DM to improve gly-
cemic control and cardiovascular risk factors.
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